Status:
COMPLETED
Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.
Lead Sponsor:
State University of New York at Buffalo
Conditions:
Parkinson's Disease
Eligibility:
All Genders
Brief Summary
In this investigator-initiated study, we will compare changes in brain cognitive biomarkers assessed by diffusion tensor imaging over 2.5 years among 12 patients with Idiopathic Parkinson's disease (I...
Eligibility Criteria
Inclusion
- IPD or HC subjects who were enrolled in a similar study about 2.5 years ago and for whom Baseline DTI data are available.
Exclusion
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT02278588
Start Date
November 1 2014
End Date
December 1 2017
Last Update
February 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University at Buffalo
Buffalo, New York, United States, 14214